Systematic expression of immediate early genes and intensive astrocyte activation induced by intrastriatal ferrous iron injection

Brain Research

Volumn 828, Issue 1-2, 1999, Pages 145-153

  Hironishi, Masaya ^a   Ueyama, Eiko ^a   Senba, Emiko ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

C fos; Hydroxyl radical; Immediate early gene; Iron; Oxidative stress; Parkinson's disease

Indexed keywords

BROMOCRIPTINE MESILATE; DIMETHYL SULFOXIDE; DOPAMINE; FERRIC CHLORIDE; HYDROXYL RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; GENE EXPRESSION; IMMEDIATE EARLY GENE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; ASTROCYTES; BEHAVIOR, ANIMAL; COLORING AGENTS; CORPUS STRIATUM; DOPAMINE; FERROCYANIDES; FERROUS COMPOUNDS; GENES, IMMEDIATE-EARLY; GENICULATE BODIES; HYDROXYL RADICAL; MALE; MICROINJECTIONS; OXIDATIVE STRESS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SYMPATHOLYTICS;

EID: 0033562508     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01356-6     Document Type: Article

References (53)

1. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
2. Bains J.S., Shaw C.A. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Rev. 25:1997;335-358.
3. Balazs L., Leon M. Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem. Res. 19:1994;1131-1137.
4. Ben-Shachar D., Youdim M.B.H. Intranigral iron injection induces behavioral and biochemical 'parkinsonism' in rats. J. Neurochem. 57:1991;2133-2135.
5. Bennett S.A., Stevenson B., Staines W.A., Roberts D.C. Periodic acid-Schiff (PAS)-positive deposits in brain following kainic acid-induced seizures: relationships to fos induction, neuronal necrosis, reactive gliosis, and blood-brain barrier breakdown. Acta Neuropathol. 89:1995;126-138.
6. Biaglow J.E., Kachur A.V. The generation of hydroxyl radicals in the reaction of molecular oxygen with polyphosphate complexes of ferrous ion. Rad. Res. 148:1997;181-187.
7. Bjelke B., Stromberg I., O'Connor W.T., Andbjer B., Agnati L.F., Fuxe K. Evidence for volume transmission in the dopamine denervated neostriatum of the rat after a unilateral nigral 6-OHDA microinjection. Studies with systemic D-amphetamine treatment. Brain Res. 662:1994;11-24.
8. Burkitt M.J., Mason R.P. Direct evidence for in vivo hydroxyl-radical generation in experimental iron overload: an ESR spin-trapping investigation. Proc. Natl. Acad. Sci. U.S.A. 88:1991;8440-8444.
9. Cole A.J., Saffen D.W., Baraban J.M., Worley P.F. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature. 340:1989;474-476.
10. J.R. Connor, Evidence for iron mismanagement in the brain in neurological disorders, in: J.R. Connor (Ed.), Metals and Oxidative Damage in Neurological Disorders, Plenum, New York, 1997, pp. 23-39.
11. Connor J.R., Menzies S.L., St. Martin S.M., Mufson E.J. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J. Neurosci. Res. 31:1992;75-83.
12. Connor J.R., Snyder B.S., Beard J.L., Fine R.E., Mufson E.J. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J. Neurosci. Res. 31:1992;327-335.
13. Del Maestro R., Thaw H.H., Bjork J., Planker M., Arfors K.E. Free radicals as mediators of tissue injury. Acta Physiol. Scand. 492:1980;43-57.
14. D.T. Dexter, P. Jenner, Alterations in iron in neurodegenerative disorders: implications and possible therapeutic agents, in: M. Yasui, M.J. Strong, K. Ota, M.A. Verity (Eds.), Mineral and Metal Neurotoxicology, CRC Press, Boca Raton, 1997, pp. 365-390.
15. Dragunow M., Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Methods. 29:1989;261-265.
16. Fernandez A.M., Garcia-Estrada J., Garcia-Segura L.M., Torres-Aleman I. Insulin-like growth factor I modulates c-Fos induction and astrocytosis in response to neurotoxic insult. Neuroscience. 76:1997;117-122.
17. Fong K.L., McCay P.B., Poyer J.L., Keele B.B., Misra H. Evidence that peroxidation of lysosomal membranes is initiated by hydroxyl free radicals produced during flavin enzyme activity. J. Biol. Chem. 248:1973;7792-7797.
18. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
19. Halliwell B., Grootveld M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett. 213:1987;9-14.
20. B. Halliwell, J. Gutteridge (Eds.), Free radicals in biology and medicine, Clarendon Press, Oxford, 1989.
21. P.A. Insel, Analgesic - antipyretics and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout, in: A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.), The Pharmacological Basis of Therapeutics, 8th edn., Pergamon, New York, 1990, pp. 638-670.
22. Janssen Y.M., Heintz N.H., Mossman B.T. Induction of c-fos and c-jun proto-oncogene expression by asbestos is ameliorated by N-acetyl-L-cysteine in mesothelial cells. Cancer Res. 55:1995;2085-2089.
23. Jorgensen M.B., Johansen F.F., Diemer N.H. Post-ischemic and kainic acid-induced c-fos protein expression in the rat hippocampus. Acta Neurol. Scand. 84:1991;352-356.
24. Kondo T., Ito T., Sugita Y. Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum. Annals of the New York Academy of Sciences. 738:1994;222-229.
25. L. Côté, M.D. Crutcher, The basal ganglia, in: E.R. Kandel, J.H. Schwartz, T.M. Jessell (Eds.), Principles of Neural Science, 3rd edn., Elsevier, New York, 1991, pp. 647-659.
26. Liu X.H., Kato H., Chen T., Kato K., Itoyama Y. Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil. J. Neurol. Sci. 129:1995;9-14.
27. Lloyd R.V., Hanna P.M., Mason R.P. The origin of the hydroxyl radical oxygen in the Fenton reaction. Free Radic. Biol. Med. 22:1997;885-888.
28. Lo Y.Y., Cruz T.F. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J. Biol. Chem. 270:1995;11727-11730.
29. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
30. Mantyh P.W., Ghilardi J.R., Rogers S., DeMaster E., Allen C.J., Stimson E.R., Maggio J.E. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J. Neurochem. 61:1993;1171-1174.
31. R. Meneghini, E.A.L. Martins, M. Calderaro, DNA damage by reactive oxygen species, The role of metals, in: G. Poli, E. Albano, M.U. Dianzani (Eds.), Free Radicals: From Basic Science to Medicine, Birkhäuser, Basle, 1993, pp. 102-112.
32. Mizukawa K., Kabuto H., Mori A. Morphological investigation of iron-induced epileptic rats: with special reference to c-fos immunohistochemistry and iron staining. Jpn. J. Psychiatr. Neurol. 45:1991;285-289.
33. Mohanakumar K.P., de Bartolomeis A., Wu R.-M., Yeh K.J., Sternberger L.M., Peng S.-Y., Murphy D.L., Chiueh C.C. Ferrous-citrate complex and nigral degeneration: evidence for free-radical formation and lipid peroxidation. Annals of the New York Academy of Sciences. 738:1994;392-399.
34. Nappi A.J., Vass E. Comparative studies of enhanced iron-mediated production of hydroxyl radical by glutathione, cysteine, ascorbic acid, and selected catechols. Biochim. Biophys. Acta. 1336:1997;295-302.
35. Nishibayashi S., Asanuma M., Kohno M., Gomez-Vargas M., Ogawa N. Scavenging effects of dopamine agonists on nitric oxide radicals. J. Neurochem. 67:1996;2208-2211.
36. Omanow C.W. Attempts to obtain neuroprotection in Parkinson's disease. Neurology. 49:1997;S26-33.
37. Panganamala R.V., Sharma H.M., Heikkila R.E., Geer J.C., Cornwell D.G. Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohols and methional in the inhibition of prostaglandin biosynthesis. Prostaglandins. 11:1976;599-607.
38. Pennypacker K.R., Hong J.S., McMillian M.K. Pharmacological regulation of AP-1 transcription factor DNA binding activity. FASEB J. 8:1994;475-478.
39. Powell S.R. Salicylate trapping of ·OH as a tool for studying post-ischemic oxidative injury in the isolated rat heart. Free Radic. Res. 21:1994;355-370.
40. S.J. Robb-Gaspers, J.R. Connor, Oxidative stress-induced cell damage in the CNS, A proposal for a final common pathway, in: J.R Connor (Ed.), Metals and Oxidative Damage in Neurological Disorders, Plenum, New York, 1997, pp. 341-351.
41. Sagar S.M., Sharp F.R., Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science. 240:1988;1328-1331.
42. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
43. Senba E., Ueyama T. Stress-induced expression of immediate early genes in the brain and peripheral organs of the rat. Neurosci. Res. 29:1997;183-207.
44. Sengstock G.J., Olanow C.W., Dunn A.J., Arendash G.W. Iron induces degeneration of nigrostriatal neurons. Brain Res. Bull. 28:1992;645-649.
45. Shibanuma M., Kuroki T., Nose K. Induction of DNA replication and expression of proto-oncogenes c-myc and c-fos in quiescent Balb/3T3 cells by xanthine/xanthine oxidase. Oncogene. 3:1988;17-21.
46. L.A. Shinobu, M.F. Beal, The role of oxidative processes and metal ions in aging and Alzheimer's disease, in: J.R. Connor (Ed.), Metals and Oxidative Damage in Neurological Disorders, Plenum, New York, 1997, pp. 237-275.
47. Thompson C.M., Markesbery W.R., Ehmann W.D., Mao Y.X., Vance D.E. Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology. 9:1988;1-7.
48. 2+ injection. J. Neurochem. 42:1984;976-980.
49. Victoria E.J., Barber A.A. Peroxidation of microsomal membrane protein-lipid complexes. Lipids. 4:1969;582-588.
50. Wardman P., Candeias L.P. Fenton chemistry: an introduction. Rad. Res. 145:1996;523-531.
51. Yoshikawa T., Minamiyama Y., Naito Y., Kondo M. Antioxidant properties of bromocriptine, a dopamine agonist. J. Neurochem. 62:1994;1034-1038.
52. Youdim M.B.H., Riederer P. The role of iron in senescence of dopaminergic neurons in Parkinson's disease. J. Neural Transm. 40:1993;57-67.
53. Zimmer L.A., Ennis M., Wiley R.G., Shipley M.T. Nerve gas-induced seizures: role of acetylcholine in the rapid induction of Fos and glial fibrillary acidic protein in piriform cortex. J. Neurosci. 18:1998;3897-3908.